David Stolick, Chief Financial Officer at BRAINSTORM CELL THERAPEUTICS INC (BCLI), sold 150,000 shares at $0.36 ($54K) on 2010-02-16, disclosed to the SEC on 2010-02-19.
Open-market sale of $54k BCLI by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.36 | 5,000 | $2K | 3.3% |
| 2 | $0.36 | 3,000 | $1K | 2.0% |
| 3 | $0.36 | 140,000 | $50K | 93.3% |
| 4 | $0.36 | 2,000 | $720 | 1.3% |
| Total | $0.36 avg | 150,000 | $54K | 100% |